DRUG
Bright Minds Biosciences Inc
NASDAQ · Biotechnology
$75.97
+2.89 (+3.95%)
Open$74.79
Previous Close$73.08
Day High$77.75
Day Low$74.63
52W High$170.00
52W Low$33.01
Volume—
Avg Volume630
Market Cap1.03B
P/E Ratio—
EPS$-1.75
SectorBiotechnology
Analyst Ratings
Strong Buy
7 analysts
Price Target
-64.5% upside
Current
$75.97
$75.97
Target
$26.95
$26.95
$16.82
$26.95 avg
$32.06
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 177.09M | 163.76M | 147.32M |
| Net Income | 34.74M | 43.56M | 40.99M |
| Profit Margin | 19.6% | 26.6% | 27.8% |
| EBITDA | 73.10M | 70.32M | 54.60M |
| Free Cash Flow | 20.82M | 31.20M | 18.21M |
| Rev Growth | -5.5% | +4.9% | +20.1% |
| Debt/Equity | 0.67 | 0.83 | 0.74 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |